We are live on !
Find out more
PCA
Private Capital Advisors Portfolio holdings
AUM
$1.15B
Turnover
18.82%
1-Year Est. Return
43.46%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$266M
AUM Growth
-$43.4M
(-14%)
Cap. Flow
-$44.2M
Cap. Flow % of AUM
Cap. Flow %
-16.65%
Top 10 Holdings %
Top 10 Hldgs %
25.48%
Holding
127
New
7
Increased
6
Reduced
50
Closed
22
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$4.06M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
+$2.27M |
| 3 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
+$1.93M |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$1.56M |
| 5 |
Axon Enterprise
AXON
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RH
RH
|
+$13M |
| 2 |
MacroGenics
MGNX
|
+$6.84M |
| 3 |
Alibaba
BABA
|
+$3.42M |
| 4 |
SANGAMO THERAPEUTICS INC
SGMO
|
+$3.21M |
| 5 |
HCA Healthcare
HCA
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.9% |
| 2 | Communication Services | 19.6% |
| 3 | Energy | 16.27% |
| 4 | Industrials | 12.61% |
| 5 | Technology | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Liberty Media Corporation Series C Common Stock
FWONK
$22.8B
| $2.09M | 0.79% |
84,272
-27,874
| -25% | -$685K |
2014 Q3
1 quarter
|
|
52
Gilead Sciences
GILD
$194B
| $2.06M | 0.78% |
21,891
-2,803
| -11% | -$290K |
2013 Q2
6 quarters
|
|
|
53
Ionis Pharmaceuticals
IONS
$7.14B
| $1.95M | 0.73% |
+31,600
| New | +$1.56M |
2014 Q4
0 quarters
|
|
54
iShares Select Dividend ETF
DVY
$23.2B
| $1.84M | 0.69% |
23,175
| – | – |
2013 Q2
6 quarters
|
|
|
DISCK
55
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.84M | 0.69% |
54,450
-1,725
| -3% | -$58.8K |
2014 Q3
1 quarter
|
|
56
DELISTED
Warner Bros
WBD
| $1.79M | 0.67% |
52,030
-3,525
| -6% | -$122K |
2014 Q3
1 quarter
|
|
57
MiMedx Group
MDXG
$646M
| $1.69M | 0.64% |
146,286
| – | – |
2013 Q2
6 quarters
|
|
58
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
| $1.65M | 0.62% |
103,805
-600
| -0.6% | -$9.5K |
2013 Q2
6 quarters
|
|
|
59
Axon Enterprise
AXON
$31.7B
| $1.48M | 0.56% |
+56,000
| New | +$1.1M |
2014 Q4
0 quarters
|
|
60
Abbott
ABT
$181B
| $1.48M | 0.56% |
32,850
| – | – |
2013 Q2
6 quarters
|
|
|
MWV
61
DELISTED
MEADWESTVACO CORP
MWV
| $1.42M | 0.53% |
31,909
| – | – |
2013 Q2
6 quarters
|
|
62
Verizon
VZ
$186B
| $1.27M | 0.48% |
27,180
-269
| -1% | -$13.2K |
2014 Q1
3 quarters
|
|
63
Omnicom Group
OMC
$22.1B
| $1.24M | 0.47% |
16,000
| – | – |
2013 Q2
6 quarters
|
|
64
Johnson & Johnson
JNJ
$616B
| $1.14M | 0.43% |
10,888
| – | – |
2013 Q2
6 quarters
|
|
65
Liberty Media Corporation Series A Common Stock
FWONA
$20.9B
| $1.05M | 0.4% |
44,329
-14,574
| -25% | -$344K |
2013 Q2
6 quarters
|
|
|
TWTR
66
DELISTED
Twitter, Inc.
TWTR
| $1.02M | 0.39% |
28,508
-5,982
| -17% | -$255K |
2014 Q2
2 quarters
|
|
67
Charter Communications
CHTR
$12.6B
| $866K | 0.33% |
5,200
| – | – |
2013 Q2
6 quarters
|
|
68
CVS Health
CVS
$118B
| $814K | 0.31% |
8,450
| – | – |
2013 Q2
6 quarters
|
|
69
CVR Partners
UAN
$1.34B
| $808K | 0.3% |
8,291
| – | – |
2013 Q2
6 quarters
|
|
70
Coca-Cola
KO
$404B
| $760K | 0.29% |
18,000
-49,818
| -73% | -$2.13M |
2013 Q2
6 quarters
|
|
71
DELISTED
Liberty Broadband Class C
LBRDK
| $743K | 0.28% |
+14,908
| New | +$734K |
2014 Q4
0 quarters
|
|
|
DISH
72
DELISTED
DISH Network Corp.
DISH
| $743K | 0.28% |
10,200
| – | – |
2013 Q2
6 quarters
|
|
73
Microsoft
MSFT
$3.93T
| $691K | 0.26% |
14,875
| – | – |
2013 Q2
6 quarters
|
|
74
Invesco QQQ Trust
QQQ
$475B
| $691K | 0.26% |
6,690
| – | – |
2013 Q2
6 quarters
|
|
75
Ball Corp
BALL
$16.7B
| $686K | 0.26% |
20,120
| – | – |
2013 Q2
6 quarters
|
|
Similar funds
AIC
CFP
HT
AA
CIG
CIS
FWM
Private Capital Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Private Capital Advisors held 127 positions worth $266M, down 14% from $309M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Private Capital Advisors withdrew a net $44.2M in Q4 2014, closing 22 positions and reducing 50 holdings. Its most notable exit was RH, an estimated $13M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Communication Services and Energy.
Against the trend, Private Capital Advisors opened a new position in Catalyst Pharmaceutical worth $2.46M.
- Private Capital Advisors's largest Q4 2014 buy was Catalyst Pharmaceutical: 826,500 shares worth $2.46M.
- Private Capital Advisors added most to Qualcomm in Q4 2014, an estimated $4.06M increase.
- Private Capital Advisors's biggest Q4 2014 reduction was MacroGenics, cutting an estimated $6.84M.
- Private Capital Advisors fully exited RH in Q4 2014, selling an estimated $13M.
- Private Capital Advisors's ten largest holdings make up 25% of its $266M portfolio in Q4 2014.
- Private Capital Advisors opened 7 new positions and closed 22 in Q4 2014.
- Private Capital Advisors's portfolio value fell 14% quarter-over-quarter to $266M.
Based on Private Capital Advisors's 13F filing for Q4 2014, filed 29 Jan 2015.